Redmile Group LLC

Redmile Group LLC, a DE Limited Liability Company with 29 employees, 16 of whom are advisors, serves 3 clients. The firm's status with the U.S. Securities and Exchange Commission is Approved, and it has been registered since April 19, 2007.

• AMRIT NMN NAGPAL

  MANAGING DIRECTOR owns less than 5%

• BRYAN RANNEY CRAPO

  CHIEF OPERATING OFFICER owns more than 5% but less than 10%

• CHRISTOPHER CHARLES OCONNOR

  MANAGING DIRECTOR owns more than 5% but less than 10%

• JEREMY CHARLES GREEN

  MANAGING MEMBER owns more than 50% but less than 75%

• JOSHUA DAMIAN GARCIA

  CHIEF FINANCIAL OFFICER owns less than 5%

• MICHAEL STEWART LEE

  MANAGING DIRECTOR owns more than 10% but less than 25%

• OWEN JOHN LEARY

  MANAGING DIRECTOR owns less than 5%

• RACHEL NMN CHANG

  CHIEF COMPLIANCE OFFICER owns less than 5%

• ROBERT CARRINGTON FAULKNER

  MANAGING DIRECTOR owns more than 5% but less than 10%

• J.P. MORGAN SECURITIES LLC
  United States
• J.P. MORGAN CLEARING CORP.
  United States
• MORGAN STANLEY & CO. LLC
  United States
• MORGAN STANLEY & CO. LLC
  United States

• ABD Retirement Services Inc
• Sentry Advisors LLC
• QCM LLC
• SAN Francisco Sentry Investment Group
• LH Capital Management LLC
• Intellectus Partners LLC
• Menta Capital LLC
• Dedicated Capital Advisors LLC
• MERK Investments LLC
• Principly Inc

• Investing in Biotech: Redmile Group's Q3 2022 vs. Q4 2022 13F Holdings Comparison

• Array Biopharma Inc $405,492k
• AMICUS THERAPEUTICS INC $284,452k
• Fate Therapeutics Inc $210,301k
• Argenx SE Sponsored ADR $151,325k
• UNIQURE N.V. $130,473k
• AUDENTES THERAPEUTICS INC COM $112,526k
• EPIZYME INC $109,551k
• ALLAKOS INC COM $99,672k
• ALDER BIOPHARMACEUTICALS INC $97,042k
• ATARA BIOTHERAPEUTICS INC $92,524k